|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2000-4-27
|
|
pubmed:abstractText |
Heparin coating of the cardiopulmonary bypass circuit attenuates inflammatory response and confer clinical benefits in cardiac operations. The positive effects may be amplified with reduced systemic heparin dosage. We studied markers of inflammation and coagulation in thoracic aortic operations with heparin-coated circuits and standard vs reduced systemic heparinization.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0003-4975
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
69
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
743-9
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:10750754-Aged,
pubmed-meshheading:10750754-Anticoagulants,
pubmed-meshheading:10750754-Antithrombin III,
pubmed-meshheading:10750754-Aorta, Thoracic,
pubmed-meshheading:10750754-Cardiopulmonary Bypass,
pubmed-meshheading:10750754-Complement C3a,
pubmed-meshheading:10750754-Complement Membrane Attack Complex,
pubmed-meshheading:10750754-Female,
pubmed-meshheading:10750754-Heparin,
pubmed-meshheading:10750754-Humans,
pubmed-meshheading:10750754-Interleukin-6,
pubmed-meshheading:10750754-Lactoferrin,
pubmed-meshheading:10750754-Male,
pubmed-meshheading:10750754-Middle Aged,
pubmed-meshheading:10750754-Peptide Hydrolases,
pubmed-meshheading:10750754-Peroxidase,
pubmed-meshheading:10750754-Postoperative Complications
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
No benefit of reduced heparinization in thoracic aortic operation with heparin-coated bypass circuits.
|
|
pubmed:affiliation |
Department of Cardiothoracic Surgery, Uppsala University Hospital, Sweden.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
